NA
PRAX icon

NewEdge Advisors’s Praxis Precision Medicines PRAX Stock Holding History

NewEdge Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-208
Closed -$5.34K – 3848
2023
Q3 		$5.34K Buy
+208
New +$3.94K ﹤0.01% 2787

Other funds holding PRAX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

NewEdge Advisors's PRAX Position: Q4 2023 in Review

NewEdge Advisors sold out of Praxis Precision Medicines (PRAX) in Q4 2023, closing a stake of 208 shares — an estimated $5.34K sold.

NewEdge Advisors first reported a position in PRAX in Q3 2023 and held it in 1 quarter. The position peaked at $5.34K in Q3 2023. 60 funds tracked by Wall St. Rank hold PRAX as of Q4 2023.

  • NewEdge Advisors reported no remaining Praxis Precision Medicines position as of Q4 2023 after selling out during the quarter.
  • NewEdge Advisors sold 208 Praxis Precision Medicines shares in Q4 2023, an estimated $5.34K.
  • NewEdge Advisors first reported a position in Praxis Precision Medicines in Q3 2023 and held it in 1 quarter.
  • NewEdge Advisors's Praxis Precision Medicines position peaked at $5.34K in Q3 2023.
  • 60 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2023.

Based on NewEdge Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.